Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > Revenue growth is our sticky wicket, yet 20% /Qtr = 100% YOY

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Nov 08, 2021 10:30am

163 Views

Post# 34099527

RE:Revenue growth is our sticky wicket, yet 20% /Qtr = 100% YOY

HomerAndCompany wrote:
The 20% per quarter revenue growth in the last two quarters translates into 100% growth on an anualized (compounded) basis. It was a miss, not what we were expecting, and certainly not what we were hoping for. But still, it is exponential growth in the face of COVID headwinds.

and hoping it ramps up from here - new/safer technology - should find a warm reception of growth

large hospitals are a problem during COVID - I get that

Woundering why there isn't a stronger pivot to clinics at this time - maybe that's what's going to happen next.

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. army